We are live on ! Find out more

196 hedge funds and large institutions have $2.01B invested in CONMED in 2018 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 65 increasing their positions, 64 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 15

43% more call options, than puts

Call options by funds: $1.24M | Put options by funds: $864K

17% more capital invested

Capital invested by funds: $1.73B → $2.01B (+$288M)

13% more funds holding

Funds holding: 173196 (+23)

1.08% more ownership

Funds ownership: 97.47%98.55% (+1.1%)

2% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 64

Holders
196
Holders Change
+23
Holders Change %
+13.29%
% of All Funds
4.49%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
40
Increased
65
Reduced
64
Closed
15
Calls
$1.24M
Puts
$864K
Net Calls
+$373K
Net Calls Change
+$423K

CNMD Hedge Fund Activity: Q2 2018 in Review

196 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q2 2018, worth a combined $2.01B — up 17% from $1.73B a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new CNMD positions and 15 closed out — a net gain of 25 holders — while 65 added to existing stakes and 64 trimmed.

The largest buyer was Hood River Capital Management, opening a new position worth an estimated $23.6M. The largest seller was Victory Capital Management, cutting an estimated $40.8M.

  • 196 institutional investors held CONMED (CNMD) as of Q2 2018, up from 173 in Q1 2018.
  • Funds reported $2.01B of CONMED stock for Q2 2018, up 17% quarter-over-quarter.
  • 40 funds opened new CONMED positions in Q2 2018 and 15 closed out, a net change of +25 holders.
  • The largest CONMED buyer in Q2 2018 was Hood River Capital Management, an estimated $23.6M added.
  • The largest CONMED seller in Q2 2018 was Victory Capital Management, an estimated $40.8M sold.

Based on aggregated 13F filings for Q2 2018.